Physician profile
Shankar Baskar
NPI 1487918751
$4,873.69
in general payments reported to CMS, 2019-2025
8 companies · $3,076 in 2025
The $3,076 reported for 2025 was more than what 89% of Pediatric Cardiology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.27 · 2022: $95.33 · 2023: $63.08 · 2024: $1,619 · 2025: $3,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,101 · Food and Beverage: $1,457 · Consulting Fee: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,100.94 |
| Food and Beverage | $1,457.15 |
| Consulting Fee | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,495.33 | 2022-2025 | Micra, Aurora Ev-Icd Mri Surescan |
| Altathera Pharmaceuticals LLC | $1,382.42 | 2024 | Sotalol Hydrochloride |
| Abbott Laboratories | $1,362.99 | 2025 | Aveir |
| Biosense Webster, INC. | $458.42 | 2023-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Boston Scientific Corporation | $121.34 | 2020-2024 | Emblem Mri S-Icd |
| Atricure, INC. | $18.98 | 2025 | Atriclip Laa Exclusion System |
| Cardiva Medical, INC. | $17.64 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.57 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shankar Baskar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.